000 | 01340 a2200385 4500 | ||
---|---|---|---|
005 | 20250517170651.0 | ||
264 | 0 | _c20180725 | |
008 | 201807s 0 0 eng d | ||
022 | _a1095-9327 | ||
024 | 7 |
_a10.1016/j.mcn.2017.08.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcDowall, Jennifer S | |
245 | 0 | 0 |
_aAlpha-synuclein ferrireductase activity is detectible in vivo, is altered in Parkinson's disease and increases the neurotoxicity of DOPAL. _h[electronic resource] |
260 |
_bMolecular and cellular neurosciences _c12 2017 |
||
300 |
_a1-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xmetabolism |
650 | 0 | 4 |
_aFMN Reductase _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aParkinson Disease _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aalpha-Synuclein _xmetabolism |
700 | 1 | _aNtai, Ioanna | |
700 | 1 | _aHoneychurch, Kevin C | |
700 | 1 | _aHart, John P | |
700 | 1 | _aColin, Philippe | |
700 | 1 | _aSchneider, Bernard L | |
700 | 1 | _aBrown, David R | |
773 | 0 |
_tMolecular and cellular neurosciences _gvol. 85 _gp. 1-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mcn.2017.08.001 _zAvailable from publisher's website |
999 |
_c27468617 _d27468617 |